InflaRx plans to launch a Phase 2 clinical trial to evaluate its experimental oral treatment, izicopan, in people with ANCA-associated vasculitis (AAV). The company believes izicopan has the potential to be a safer, faster, and more convenient alternative to Tavneos (avacopan), an oral therapy with a similar…
Discussion
For many of us living with ANCA-associated vasculitis — or supporting a partner who is — intimacy may not be at the top of our daily priorities, which is understandable. When we are managing symptoms, medications, appointments, and the sheer effort it takes to get through the day, connection…
May is Vasculitis Awareness Month, and advocates are gearing up to raise awareness, foster connection within the community, and raise funds to fuel research into ANCA-associated vasculitis (AAV) and other disorders that are marked by blood vessel inflammation. This year’s awareness month coincides with the 40th anniversary of…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
